Currently, there are 1.26B common shares owned by the public and among those 1.26B shares have been available to trade.
The company’s stock has a 5-day price change of -0.44% and -0.78% over the past three months. CVS shares are trading 24.64% year to date (YTD), with the 12-month market performance down to -24.77% lower. It has a 12-month low price of $43.56 and touched a high of $80.75 over the same period. CVS has an average intraday trading volume of 13.89 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 7.04%, 7.71%, and -2.55% respectively.
Institutional ownership of CVS Health Corp (NYSE: CVS) shares accounts for 81.36% of the company’s 1.26B shares outstanding.
It has a market capitalization of $70.41B and a beta (3y monthly) value of 0.61. The stock’s trailing 12-month PE ratio is 14.22, while the earnings-per-share (ttm) stands at $3.94. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.86% over the week and 3.04% over the month.
Earnings per share for the fiscal year are expected to decrease by -41.09%, and 13.96% over the next financial year.
Deutsche Bank coverage for the CVS Health Corp (CVS) stock in a research note released on December 03, 2024 offered a Buy rating with a price target of $66. Wells Fargo was of a view on November 18, 2024 that the stock is Overweight, while Barclays gave the stock Overweight rating on October 10, 2024, issuing a price target of $63- $82. TD Cowen on their part issued Buy rating on October 04, 2024.
